BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16301926)

  • 1. Does compliance therapy improve use of antipsychotic medication?
    Ilott R
    Br J Community Nurs; 2005 Nov; 10(11):514-9. PubMed ID: 16301926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From compliance to concordance: a review of the literature on interventions to enhance compliance with antipsychotic medication.
    Gray R; Wykes T; Gournay K
    J Psychiatr Ment Health Nurs; 2002 Jun; 9(3):277-84. PubMed ID: 12060371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pimozide for schizophrenia or related psychoses.
    Mothi M; Sampson S
    Cochrane Database Syst Rev; 2013 Nov; (11):CD001949. PubMed ID: 24194433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An RCT of adherence therapy for people with schizophrenia in Chiang Mai, Thailand.
    Maneesakorn S; Robson D; Gournay K; Gray R
    J Clin Nurs; 2007 Jul; 16(7):1302-12. PubMed ID: 17584349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does adherence therapy improve medication adherence among patients with schizophrenia? A systematic review.
    Hegedüs A; Kozel B
    Int J Ment Health Nurs; 2014 Dec; 23(6):490-7. PubMed ID: 25279684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of interventions to improve compliance with antipsychotic medication in people suffering from schizophrenia-results of recent reviews].
    Puschner B; Born A; Giessler A; Helm H; Becker T; Angermeyer MC
    Psychiatr Prax; 2005 Mar; 32(2):62-7. PubMed ID: 15712037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interventions to improve adherence to antipsychotic medication in patients with schizophrenia--a review of the past decade.
    Barkhof E; Meijer CJ; de Sonneville LM; Linszen DH; de Haan L
    Eur Psychiatry; 2012 Jan; 27(1):9-18. PubMed ID: 21561742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effectiveness of compliance therapy on drug attitude among schizophrenic patients: a systematic review.
    Chang YT; Lee LL
    JBI Database System Rev Implement Rep; 2015 Aug; 13(7):213-40. PubMed ID: 26455856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A trial of compliance therapy in outpatients with schizophrenia or schizoaffective disorder.
    Byerly MJ; Fisher R; Carmody T; Rush AJ
    J Clin Psychiatry; 2005 Aug; 66(8):997-1001. PubMed ID: 16086614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication management for people with a diagnosis of schizophrenia.
    Gray R; Robson D; Bressington D
    Nurs Times; 2002 Nov 19-25; 98(47):38-40. PubMed ID: 12494838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TAILOR - tapered discontinuation versus maintenance therapy of antipsychotic medication in patients with newly diagnosed schizophrenia or persistent delusional disorder in remission of psychotic symptoms: study protocol for a randomized clinical trial.
    Stürup AE; Jensen HD; Dolmer S; Birk M; Albert N; Nielsen M; Hjorthøj C; Eplov L; Ebdrup BH; Mors O; Nordentoft M
    Trials; 2017 Sep; 18(1):445. PubMed ID: 28962668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive behaviour therapy for schizophrenia.
    Cormac I; Jones C; Campbell C
    Cochrane Database Syst Rev; 2002; (1):CD000524. PubMed ID: 11869579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A narrative meta-synthesis of how people with schizophrenia experience facilitators and barriers in using antipsychotic medication: Implications for healthcare professionals.
    Salzmann-Erikson M; Sjödin M
    Int J Nurs Stud; 2018 Sep; 85():7-18. PubMed ID: 29803018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Compliance in schizophrenia: predictive factors, therapeutical considerations and research implications].
    Misdrahi D; Llorca PM; Lançon C; Bayle FJ
    Encephale; 2002; 28(3 Pt 1):266-72. PubMed ID: 12091789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled trial of cognitive-behavioral therapy for persistent symptoms in schizophrenia resistant to medication.
    Sensky T; Turkington D; Kingdon D; Scott JL; Scott J; Siddle R; O'Carroll M; Barnes TR
    Arch Gen Psychiatry; 2000 Feb; 57(2):165-72. PubMed ID: 10665619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compliance therapy: an intervention to improve inpatients' attitudes toward treatment.
    Tay SE
    J Psychosoc Nurs Ment Health Serv; 2007 Jun; 45(6):29-37. PubMed ID: 17601158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophrenia.
    Morken G; Widen JH; Grawe RW
    BMC Psychiatry; 2008 Apr; 8():32. PubMed ID: 18447935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schizophrenia: attitudes of patients and professional carers towards the illness and antipsychotic medication.
    Rettenbacher MA; Burns T; Kemmler G; Fleischhacker WW
    Pharmacopsychiatry; 2004 May; 37(3):103-9. PubMed ID: 15138893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.